Multiple Myeloma News and Research

Latest Multiple Myeloma News and Research

Cancer patients have higher risk of cardiovascular death

A new study says that over 10% of patients with cancer die of unrelated cardiovascular disease (CVD) rather than their cancers.

25 Nov 2019

Risk of death from heart disease found to be higher in cancer patients

More than one in ten cancer patients do not die from their cancer but from heart and blood vessel problems instead, according to new research published in the European Heart Journal today. For some cancers, like breast, prostate, endometrial, and thyroid cancer, around half will die from cardiovascular disease (CVD).

25 Nov 2019

Fosun Pharma, MimiVax to jointly develop and commercialize SurVaxM therapy in U.S.

The inventors of a new and unique cancer immunotherapy developed at Roswell Park Comprehensive Cancer Center have announced a major step forward with that therapy, known as SurVaxM. MimiVax LLC principals Robert Fenstermaker, MD, and Michael Ciesielski, PhD, have announced that the company, spun off from Roswell Park in 2012, has entered into a China-exclusive licensing agreement for SurVaxM with Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd., a wholly-owned subsidiary of Shanghai Fosun Pharmaceutical Co. Ltd. based in Shanghai, China.

20 Nov 2019

New device separates malignant plasma cells from normal ones

Multiple myeloma is a type of blood cancer in which malignant plasma cells, a type of white blood cell, accumulate in the bone marrow.

19 Nov 2019

New microfluidics device detects malignant multiple myeloma cells in blood

Scientists have developed a microfluidics device that could be used for the detection or monitoring of multiple myeloma.

19 Nov 2019

Gene-editing technique CRISPR trialed for first time as cancer treatment

The go-ahead has been given for the first trials using CRISPR as an alternative therapy for treating cancer.

6 Nov 2019

Three UCLA researchers receive multimillion-dollar grant from state's stem cell agency

Three researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have received awards totaling more than $18 million from the California Institute for Regenerative Medicine, the state's stem cell agency.

31 Oct 2019

NCCN publishes new clinical practice guidelines for hematopoietic cell transplantation

Today, the National Comprehensive Cancer Network published new NCCN Clinical Practice Guidelines in Oncology for Hematopoietic Cell Transplantation, also known as stem cell transplant or historically as bone marrow transplant.

30 Oct 2019

Cancer drug may delay progression of bone and other myeloma-related organ damage

The largest randomized trial in asymptomatic patients with smoldering multiple myeloma suggests that lenalidomide, a cancer drug, may delay the onset of bone and other myeloma-related organ damage.

28 Oct 2019

New screening test detects 20 types of cancer

Researchers from the Dana-Farber Cancer Institute have developed a new blood test that would accurately determine the presence of several types of cancers. The results of their multi-centre clinical trial to prove the effectiveness of their test was presented by the researchers at the European Society for Medical Oncology (ESMO) 2019 Congress in Barcelona, Spain, on the 28th of September 2019.

30 Sep 2019

New blood test shows ability to accurately detect numerous types of cancer

A new blood test in development has shown ability to screen for numerous types of cancer with a high degree of accuracy, a trial of the test shows.

28 Sep 2019

New method harnesses the power of killer T cells to attack tumor cells, treat cancer

They've been called the "special forces" of the immune system: invariant natural killer T cells. Although there are relatively few of them in the body, they are more powerful than many other immune cells.

24 Sep 2019

Mitochondrial fission factor could represent a promising target for cancer therapy

Researchers at The Wistar Institute have described the role of mitochondrial fission factor (MFF) in controlling survival of cancer cells, suggesting the protein could represent a promising therapeutic target. They also found that expression of MFF is regulated by Myc, a ubiquitous mediator of cell proliferation that contributes to development of many cancer types.

20 Sep 2019

Exposure to 9/11 WTC dust associated with increased risk of heart disease in NYC firefighters

A new study of New York City firefighters has found that exposure to 9/11 World Trade Center dust is associated with a significantly increased long-term risk of cardiovascular disease.

7 Sep 2019

Younger people getting cancer due to obesity

Obesity rates around the globe are ballooning - literally! Approximately 1.9 billion adults who are 18 years and older were overweight in 2016, and of these, more than 650 million were obese. The number of obese people has nearly tripled since 1975.

4 Sep 2019

New therapy found to be effective for patients with a particular type of bone marrow cancer

Mount Sinai researchers have found a new type of therapy to be effective for patients with a particular type of bone marrow cancer that is resistant to several standard therapies, according to results of a clinical trial published in The New England Journal of Medicine in August.

22 Aug 2019

Cancer survivors could be at greater risk of cardiovascular diseases

Over the last few decades, medical progress has led to the survival of many more people with cancer. However, a new study published in The Lancet shows that this cohort has a higher risk of cardiovascular disease (CVD) than controls without cancer, due to a number of reasons.

21 Aug 2019

Roswell Park receives more than $15 million in grants for cancer research

Roswell Park Comprehensive Cancer Center researchers have received more than a dozen recent grant awards totaling more than $15.4 million.

14 Aug 2019

UAMS Myeloma Center receives $542,486 grant from Leukemia & Lymphoma Society

Brian Walker, Ph.D., with the Myeloma Center at the University of Arkansas for Medical Sciences has received a $542,486, three-year grant from the Leukemia & Lymphoma Society to look at changes in the DNA sequence that effects the development and advancement of multiple myeloma, a cancer of plasma cells in the blood.

12 Aug 2019

Study finds new way to help cancer doctors predict blood clots in patients with multiple myeloma

New research from the Hutchinson Institute for Cancer Outcomes Research- which is based at Fred Hutchinson Cancer Research Center- along with the University of Washington and the Seattle Cancer Care Alliance, identifies a simple way to help cancer doctors caring for patients with multiple myeloma to predict blood clots in order to take preventive action.

19 Jul 2019

Multiple Myeloma News and Research

Latest Multiple Myeloma News and Research

Cancer patients have higher risk of cardiovascular death

Risk of death from heart disease found to be higher in cancer patients

Fosun Pharma, MimiVax to jointly develop and commercialize SurVaxM therapy in U.S.

New device separates malignant plasma cells from normal ones

New microfluidics device detects malignant multiple myeloma cells in blood

Gene-editing technique CRISPR trialed for first time as cancer treatment

Three UCLA researchers receive multimillion-dollar grant from state's stem cell agency

NCCN publishes new clinical practice guidelines for hematopoietic cell transplantation

Cancer drug may delay progression of bone and other myeloma-related organ damage

New screening test detects 20 types of cancer

New blood test shows ability to accurately detect numerous types of cancer

New method harnesses the power of killer T cells to attack tumor cells, treat cancer

Mitochondrial fission factor could represent a promising target for cancer therapy

Exposure to 9/11 WTC dust associated with increased risk of heart disease in NYC firefighters

Younger people getting cancer due to obesity

New therapy found to be effective for patients with a particular type of bone marrow cancer

Cancer survivors could be at greater risk of cardiovascular diseases

Roswell Park receives more than $15 million in grants for cancer research

UAMS Myeloma Center receives $542,486 grant from Leukemia & Lymphoma Society

Study finds new way to help cancer doctors predict blood clots in patients with multiple myeloma

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Multiple Myeloma News and Research

Latest Multiple Myeloma News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in